This inventor holds 4 USPTO granted patents. Top assignee: Glaxo Group Limited. Active years: 1986-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Slough, GB (1986)
- Greenford, GB (1994 - 1995)
- Stevenage, GB (2000)
Company Filing History:
Years Active: 1986-2000
Title: David Noble: Innovator in Biochemical Patents
Introduction
David Noble is a distinguished inventor based in Greenford, GB. He has made significant contributions to the field of biochemistry, particularly through his innovative patents. With a total of 4 patents to his name, Noble has established himself as a key figure in his area of expertise.
Latest Patents
Noble's latest patents include a process for the preparation of N-acetylneuraminic acid, which describes a method for the preparation of N-acetyl-D-neuraminic acid (NANA) and N-acetyl-D-glucosamine (NAG). Another notable patent involves cyclic ketal derivatives, which are compounds that inhibit the enzyme squalene synthase and may be beneficial in lowering blood plasma cholesterol levels and combating fungal infections in animals.
Career Highlights
David Noble has worked with Glaxo Group Limited, where he has been able to apply his innovative ideas in a practical setting. His work has contributed to advancements in the pharmaceutical industry, particularly in the development of compounds that have therapeutic applications.
Collaborations
Noble has collaborated with notable coworkers such as Michael John Dawson and Allan Baxter, further enhancing the impact of his work in the field.
Conclusion
David Noble's contributions to biochemistry through his patents reflect his innovative spirit and dedication to advancing scientific knowledge. His work continues to influence the pharmaceutical industry and improve health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile